Cryptococcus gattii R265 is a hypervirulent fungal strain responsible for the recent outbreak of cryptococcosis in Vancouver Island of British Columbia in Canada. It differs significantly from Cryptococcus neoformans in its natural environment, its preferred site in the mammalian host, and its pathogenesis. Our previous studies of C. neoformans have shown that the presence of chitosan, the deacetylated form of chitin, in the cell wall attenuates inflammatory responses in the host, while its absence induces robust immune responses, which in turn facilitate clearance of the fungus and induces a protective response. The results of the present investigation reveal that the cell wall of C. gattii R265 contains a two- to threefold larger amount of chitosan than that of C. neoformans. The genes responsible for the biosynthesis of chitosan are highly conserved in the R265 genome; the roles of the three chitin deacetylases (CDAs) have, however, been modified. To deduce their roles, single and double CDA deletion strains and a triple CDA deletion strain were constructed in a R265 background and were subjected to mammalian infection studies. Unlike C. neoformans where Cda1 has a discernible role in fungal pathogenesis, in strain R265, Cda3 is critical for virulence. Deletion of either CDA3 alone or in combination with another CDA (cda1Δ3Δ or cda2Δ3Δ) or both (cda1Δ2Δ3Δ) rendered the fungus avirulent and cleared from the infected host. Moreover, the cda1Δ2Δ3Δ strain of R265 induced a protective response to a subsequent infection with R265. These studies begin to illuminate the regulation of chitosan biosynthesis of C. gattii and its subsequent effect on fungal virulence. IMPORTANCE The fungal cell wall is an essential organelle whose components provide the first line of defense against host-induced antifungal activity. Chitosan is one of the carbohydrate polymers in the cell wall that significantly affects the outcome of host-pathogen interaction. Chitosan-deficient strains are avirulent, implicating chitosan as a critical virulence factor. C. gattii R265 is an important fungal pathogen of concern due to its ability to cause infections in individuals with no apparent immune dysfunction and an increasing geographical distribution. Characterization of the fungal cell wall and understanding the contribution of individual molecules of the cell wall matrix to fungal pathogenesis offer new therapeutic avenues for intervention. In this report, we show that the C. gattii R265 strain has evolved alternate regulation of chitosan biosynthesis under both laboratory growth conditions and during mammalian infection compared to that of C. neoformans.
The intrinsic resistance of Cryptococcus neoformans to the cell wall inhibitor caspofungin limits the available therapies for treating cryptococcal infections. We screened a collection of more than 4,000 gene deletion strains for altered caspofungin sensitivity to identify biological processes that could be targeted to render the cell more susceptible to caspofungin.
29Cryptococcus gattii R265 is a hyper-virulent fungal strain responsible for the major outbreak of 30 cryptococcosis in Vancouver Island of British Columbia in 1999. It differs significantly from C. 31 neoformans in its natural environment, its preferred site in the mammalian host, and in the nature 32 and mode of pathogenesis. Our previous studies in C. neoformans have shown that the presence 33 of chitosan, the deacetylated form of chitin, in the cell wall attenuates inflammatory responses in 34 the host, while its absence induces robust immune responses, which in turn facilitate clearance of 35 the fungus and induces a protective response. The results of the present investigation reveal that 36 the cell wall of C. gattii R265 contains 2-3-fold higher amount of chitosan compared to that of C. 37 neoformans. The genes responsible for the biosynthesis of chitosan are highly conserved in the 38 R265 genome; the roles of the three chitin deacetylases (CDA) have however, been modified. To 39 deduce their roles, single, double and a triple CDA deletion strains were constructed in a R265 40 background and were subjected to mammalian infection studies. Unlike C. neoformans where 41 Cda1 has a discernible role in fungal pathogenesis, in R265 Cda3 is critical for virulence. 42 Deletion of either CDA3 alone (cda3Δ) or in combination with either CDA1 (cda1Δ3Δ) or CDA2 43 (cda2Δ3Δ) or both (cda1Δ2Δ3Δ) rendered the yeast cells avirulent and were cleared from the 44 infected host. Moreover, the cda1D2D3D strain of R265 induced a protective response to a 45 subsequent infection with R265. These studies shed more light into the regulation of chitosan 46 biosynthesis of C. gattii and its subsequent effect on fungal virulence. 47 48 49 50 3 Importance: 51The fungal cell wall is an essential organelle whose components provide the first line of defense 52 against host-induced antifungal activity. Chitosan is one of the carbohydrate polymers in the cell 53 wall that significantly affects the outcome of host-pathogen interaction. Chitosan-deficient 54 strains are avirulent, implicating chitosan as a critical virulence factor. C. gattii R265 is an 55 important fungal pathogen of concern due to its ability to cause infections in individuals with no 56 apparent immune dysfunction and an increasing geographical distribution. Characterization of 57 the fungal cell wall and understanding the contribution of individual molecules of the cell wall 58 matrix to fungal pathogenesis offers new therapeutic avenues for intervention. In this report, we 59 show that the C. gattii R265 strain has evolved alternate regulation of chitosan biosynthesis 60 under both laboratory growth conditions and during mammalian infection compared to that of C. 61 neoformans. 62 63 64 65 66 67 68 69 70 71 4
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.